⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15228369 | 0.72 | — | — | |
| Ethane SCHEMBL28805784 | 0.68 | — | — | |
| SCHEMBL13539370 | 0.55 | — | — | |
| SCHEMBL4564071 | 0.53 | — | — | |
| SCHEMBL4781154 | 0.50 | — | — | |
| SCHEMBL5462925 | 0.50 | — | — | |
| SCHEMBL11809662 | 0.48 | — | — | |
| SCHEMBL11700699 | 0.46 | GAA (0.33) | — | |
| SCHEMBL5074259 | 0.46 | — | — | |
| SCHEMBL320324 | 0.46 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3331848-A1 | A PROCESS FOR PREPARING AGONIST | Vamsi Labs Ltd. (IN) | 2018-06-13 | — | — | EP | claimed |
| WO-2017021982-A1 | A PROCESS FOR PREPARING β AGONIST | VAMSI LABS LTD. (IN) | 2017-02-09 | — | — | WO | claimed |
| EP-3331848-A1 | A PROCESS FOR PREPARING AGONIST | Vamsi Labs Ltd. (IN) | 2018-06-13 | — | — | EP | disclosed |
| WO-2017021982-A1 | A PROCESS FOR PREPARING β AGONIST | VAMSI LABS LTD. (IN) | 2017-02-09 | — | — | WO | disclosed |
| US-20080269344-A1 | Beta2-Adrenergic Receptor Agonists | THERAVANCE BIOPHARMA R&D IP, LLC | 2008-10-30 | — | — | US | disclosed |
| US-7427639-B2 | β2-adrenergic receptor agonists | THERAVANCE, INC. (US) | 2008-09-23 | — | — | US | disclosed |
| US-20070179179-A1 | Beta2-adrenergic receptor agonists | THERAVANCE BIOPHARMA R&D IP, LLC | 2007-08-02 | — | — | US | disclosed |
| US-7217738-B2 | β2-adrenergic receptor agonists | THERAVANCE, INC. (US) | 2007-05-15 | — | — | US | disclosed |
| US-20050261338-A1 | Beta2-adrenergic receptor agonists | THERAVANCE BIOPHARMA R&D IP, LLC | 2005-11-24 | — | — | US | disclosed |
| US-6916961-B2 | β2-adrenergic receptor agonists | THERAVANCE, INC. (US) | 2005-07-12 | — | — | US | disclosed |
| US-6576793-B1 | β2-adrenergic receptor agonists | THERAVANCE, INC. | 2003-06-10 | — | — | US | disclosed |